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ABSTRACT
A 76-year-old female previously diagnosed with flexor
tenosynovitis, presented to the clinic complaining of
right wrist pain and numbness in her fingers. She was
seen again after a rheumatologic workup, which was
negative. It was noted that there was thenar atrophy
when compared to the contralateral side. She was then
scheduled for carpal tunnel release surgery. During
surgery, a large area of synovitis was encountered. A
radical synovectomy was performed and this tissue
was sent for culture and pathology. The findings were
most consistent with age-related amyloidosis. One week
after surgery, the patient was contacted by telephone
and reported that her hand numbness and tingling had
significantly improved, and she had resumed most of
her daily activities. The patient was counseled regarding
her pathology results and other manifestations of
amyloidosis. A cardiology consult was recommended.
Keywords: Tenosynovitis; Amyloid; Carpal tunnel
syndrome

INTRODUCTION
Carpal tunnel syndrome (CTS), described as the most
common peripheral mononeuropathy, is a compression
neuropathy of the median nerve at the wrist.1 When
evaluating a patient in a preoperative clinical setting,
several patient risk factors can heighten a physician’s
suspicion to CTS including: diabetes, thyroid disease,
obesity, and hypercholesterolemia.2-5 Patients often
complain of hand numbness that awakens them from
sleep at night, positional numbness during activities
such as driving, hand weakness, and loss of dexterity.
Electromyography and nerve conduction studies (EMG/
NCS) can be helpful in confirming the diagnosis and
severity of the syndrome. Although rare, amyloid
deposition in the flexor tenosynovium can sometimes be
the first sign of the presence of systemic amyloidosis;
the systemic type presents as amyloid fibrils formed
from the monomers of a mutated, hereditary or wild-

type, α-synuclein, transthyretin gene.6 Intra-operatively,
specific findings such as tissue overlying the nerve
that looks unusually thickened and of white/tan color
can alert the surgeon to the possibility of systemic
disease. If this is suspected, tissue should be sent for
pathological evaluation and the pathologist should be
alerted to the possibility of amyloidosis. Classically,
intraoperative findings consist of noninflammatory
changes of the flexor tenosynovium. However,
several histopathologic studies have demonstrated
amyloid deposition in the flexor tenosynovium, with
prevalence ranging from 2.0% to 19.0%.7, 8-11 Clinical
evidence of systemic amyloidosis range from skin
manifestations, cardiomyopathy, musculoskeletal
disease, gastrointestinal disease, renal, neurologic, and
hematologic abnormalities, and pulmonary disease.12
Therefore, it is important that surgeons are aware of
this possibility as they can set in motion a life-saving
comprehensive medical evaluation.

CASE REPORT
Clinical Evaluation
The patient is a 76-year-old female who presented to
the clinic complaining of right wrist pain and numbness
in her fingers. The patient had previously been
diagnosed with flexor tenosynovitis based on magnetic
resonance imaging (MRI). These symptoms had been
present for several months and were interfering with
her job as a writer. The patient denied any injury or
inciting event. She also denied night pain. Her physical
exam included finger numbness and mildly diminished
sensation in a median nerve distribution. Her symptoms
were reproduced with Phalen’s test, Durkin’s test, and
with Tinel’s over the carpal tunnel. She did not have
numbness reproduced with elbow hyperflexion. The
patient had mild swelling and fullness of the volar wrist,
and tenderness to palpation in this area. The patient’s
hand was otherwise neurovascularly intact. Nerve
conduction studies were not performed. The patient
was sent for rheumatologic workup to look for an
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Figure 1. Intraoperatively, the transverse carpal
ligament appeared thickened. A separate incision just
proximal to the flexor crease was made to evaluate
the flexor tendons, where a large area of synovitis was
encountered. A radical synovectomy was performed and
this tissue was sent for culture and pathology. In the
area of synovitis, the median nerve appeared enlarged
and fascicular.
etiology of her synovitis. She was seen again 2 months
later to review her rheumatologic workup, which was
negative for rheumatoid factor, HLA-B27, ANA, Anti-DS
DNA, and Anti-CCP. The patient made some activity
modifications, but her symptoms were continuing
to interfere with her daily activities, and her hand
numbness was affecting her sleep. At this visit, it was
noted that there was thenar atrophy when compared
to the contralateral side. Nonoperative management
including bracing and injections were discussed;
however, due to the patient’s progressive symptoms and
newly appreciated thenar atrophy, surgical management
was recommended. She was agreeable to carpal tunnel
release, and surgery was scheduled.
Imaging
Radiographic evaluation of the patient’s symptomatic
right wrist demonstrated diffuse soft tissue swelling
consistent with tenosynovitis, and scapholunate
joint widening, suggestive of a chronic scapholunate
ligament injury. The patient was slightly ulnar positive,
and diffuse degenerative changes were noted in the
metacarpophalangeal and interphalangeal joints. MRI
demonstrated flexor digitorum tenosynovitis and edema
within the carpal tunnel. There were no structural
abnormalities.
Intraoperative Findings
The patient underwent open right carpal tunnel release
2 weeks after her follow-up visit. Intraoperatively,
the transverse carpal ligament appeared thickened.
A separate incision just proximal to the wrist flexor
crease was made to evaluate the flexor tendons, where

86

CASE REPORTS • WJO VOL. 11 • 2022

Figure 2. H&E stain of the intraoperative biopsy,
pathologically studied. The stain exhibiting red waxy
material.

Figure 3. Examination of the specimen under Congo Red
staining under polarized light demonstrated apple green
birefringence, confirming the presence of amyloid.
a large area of synovitis was encountered. A radical
synovectomy was performed and this tissue was sent
for culture and pathology. In the area of synovitis, the
median nerve appeared enlarged and fascicular (Figure
1), which is often encountered in compressive median
neuropathy at the wrist.
Pathology
The flexor tenosynovitis underwent histopathologic
evaluation. There was no evidence of an inflammatory
synovitis. Hematoxylin and eosin (H&E) staining
demonstrated waxy red material (Figure 2). Examination
of Congo Red staining under polarized light
demonstrated apple green birefringence, confirming the
presence of amyloid (Figure 3). Liquid chromatography
tandem mass spectrometry (LC MS/MS) was performed
at Mayo Clinic Laboratories on peptides extracted
from Congo-Red positive, microdissected areas of the
paraffin embedded specimen. LC MS/MS detected a

Figure 4. Liquid chromatography tandem mass
spectrometry (LC MS/MS) on peptides extracted
from Congo-Red positive, microdissected areas of the
paraffin embedded specimen. Congo-Red staining
exhibited red material.
peptide profile consistent with ATTR (transthyretin)type amyloid deposition (Figure 4). LS MS/MS did
not detect an amino acid sequence abnormality
in the transthyretin protein. This finding is most
consistent with age-related amyloidosis. Per the Mayo
Clinic Laboratories’ recommendations, if the clinical
findings suggest hereditary transthyretin amyloidosis,
sequencing this patient’s TTR genes in conjunction with
genetic counseling is recommended.
Postoperative Follow-Up
One week after surgery, the patient was contacted
by telephone and reported that her hand numbness
and tingling had significantly improved, and she had
resumed most of her daily activities. The patient was
counseled regarding her pathology results and other
manifestations of amyloidosis. A cardiology consult was
then recommended. Her night numbness and positional
numbness resolved and her strength gradually
improved.

DISCUSSION
The two most common systemic amyloidosis diagnoses
are immunoglobulin light chain and hereditary
transthyretin amyloidosis (ATTR), which can present in
a variety of forms due to their effect on many systems
including cardiac, renal, gastrointestinal, hematologic,
and musculoskeletal.13 One of the most severe
manifestations is transthyretin amyloid cardiomyopathy
and recent advances in treatment make the timing
of the diagnosis paramount to early and effective
treatment.14
The diagnosis of CTS can often precede the
diagnosis of systemic amyloidosis by many years, yet
the lack of awareness of this link often results in a delay
in diagnosis. In 2018, a prospective study found that

10.2% of a cohort of men age > 50 years and women
> 60 years old undergoing carpal tunnel release for
seemingly idiopathic disease had amyloidosis diagnosed
from tenosynovial tissue biopsy.15 Furthermore, a study
of patients with cardiac amyloidosis found that CTS was
the presenting symptom in 16.0% of patients.16 Hand
surgeons must be aware of this link as they can set in
motion a series of life-saving events.
In this case, the patient did present with symptoms of
CTS, and provocative maneuvers of Phalen’s and Durkin’s
further confirmed this diagnosis. However, her volar wrist
swelling and prior diagnosis of flexor tenosynovitis was a
bit unusual and heightened suspicion to other etiologies
including rheumatologic diseases. Although her
preoperative workup for other etiologies was negative,
there are described red flag symptoms of amyloidosis
in the literature. Namely, in the study by Bishop et al.,15
the authors state that in males > 50 and females > 60
years old who present with either bilateral symptoms or
persistent symptoms despite multiple prior carpal tunnel
releases, amyloidosis should be considered. Additionally,
computed tomography (CT) scans can confirm synovial
thickening. An indication of amyloidosis may present
as periarticular soft tissue involvement such as masses,
absence of periarticular osteoporosis, preservation of
articular space, subchondral cysts, and joint effusion and
erosions.17
The presence of amyloid deposits from hereditary
ATTR amyloidosis in the tendons and ligaments has
been shown to be systemic; two studies in the past
5 years have highlighted that CTS was related to the
diagnosis of wild-type ATTR amyloidosis with cardiac
amyloidosis diagnosed 5 years to 9 years later.18
Approximately 50.0% of individuals with hereditary
ATTR amyloidosis develop cardiac disease; subclinical
cardiac involvement (e.g., cardiomegaly on chest
x-ray, thickening of the interventricular septum, and
granular sparkling on echocardiography) can be used
to diagnose late onset hereditary ATTR amyloidosis
occurrence in the cardiovascular system.19 However,
genetic workup and gene sequencing can be used to
suspect new pathogenic mutations.

CONCLUSION
The historical findings of the rarity of amyloidosis upon
diagnosis of CTS may be due to the misdiagnosis,
non-diagnosis, or a variety of non-disease specific
presenting symptoms. As demonstrated in previous
studies, age-related amyloidosis arthropathy can
be diagnosed in a delayed manner. A pathological
investigation into the origin of synovitis associated with
CTS intraoperatively is worthwhile due to the systemic
nature of hereditary ATTR amyloidosis. Genetic testing
after pathologic confirmation is necessary to possibly
identify and halt the progression of systemic disease.
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